Cancer in parents of persons with schizophrenia: Is there a genetic protection?

Schizophrenia Research

Volumn 139, Issue 1-3, 2012, Pages 189-193

  Gal, Gilad ^a   Goral, Aviva ^b   Murad, Havi ^c   Gross, Raz ^b   Pugachova, Inna ^d   Barchana, Micha ^e   Kohn, Robert ^f   Levav, Itzhak ^e  

^a ACADEMIC COLLEGE OF TEL AVIV YAFFO   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^d MINISTRY OF HEALTH   (Israel)

^e UNIVERSITY OF HAIFA   (Israel)

^f BROWN UNIVERSITY   (United States)

Author keywords

Cancer; Epidemiology; Family study; Genetic; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COLON CANCER; DATA BASE; FAMILY HISTORY; FEMALE; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PARENT; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RISK REDUCTION; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; THYROID CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMMUNITY HEALTH PLANNING; DATABASES, FACTUAL; FAMILY HEALTH; FEMALE; GENETIC LINKAGE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REGRESSION ANALYSIS; SCHIZOPHRENIA;

EID: 84863781484     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.04.018     Document Type: Article

References (35)

1. Barak Y., Achiron A., Mandel M., Mirecki I., Aizenberg D. Reduced cancer incidence among patients with schizophrenia. Cancer 2005, 104(12):2817-2821.
2. Bromet E.J., Dew M.A., Eaton W. Epidemiology of psychosis with special reference to schizophrenia. Textbook in Psychiatric Epidemiology 2003, 283-300. Wiley & Sons, New York. M. Tsuang, M. Tohen, G.E.P. Zahner (Eds.).
3. Catts V.S., Catts S.V., O'Toole B.I., Frost A.D.J. Cancer incidence in patients with schizophrenia and their first-degree relatives: a meta-analysis. Acta Psychiatr. Scand. 2008, 117(5):323-326.
4. Cohen M., Dembling B., Schorling J. The association between schizophrenia and cancer: a population-based mortality study. Schizophr. Res. 2002, 57(2-3):139-146.
5. Dalton S.O., Laursen T.M., Mellemkjaer L., Johansen C., Mortensen P.B. Risk for cancer in parents of patients with schizophrenia. Am. J. Psychiatry 2004, 161(5):903-908.
6. Dalton S.O., Mellemkjaer L., Thomassen L., Mortensen P.B., Johansen C. Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993. Schizophr. Res. 2005, 75(2-3):315-324.
7. Dohrenwend B.P., Levav I., Shrout P.E., Schwartz S., Naveh G., Link B.G., Skodol A.E., Stueve A. Socioeconomic status and psychiatric disorders: the causation-selection issue. Science 1992, 255(5047):946-952.
8. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., Mortensen P.B. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 2006, 163(3):521-528.
9. Freedman L.S., Al-Kayed S., Qasem M.B., Barchana M., Boyiadzis M., El-Najjar K., Ibrahim A.S., Salhab A.R., Young J.L., Roffers S., Kahan E., Harford J., Silbermann M. Cancer registration in the Middle East. Epidemiology 2001, 12:131-133.
10. Gil-Ad I., Shtaif B., Levkovitz Y., Dayag M., Zeldich E., Weizman A. Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors. J. Mol. Neurosci. 2004, 22(3):189-198.
11. Gilvarry C.M., Sham P.C., Jones P.B., Cannon M., Wright P., Lewis S.W., Bebbington P., Toone B.K., Murray R.M. Family history of autoimmune diseases in psychosis. Schizophr. Res. 1996, 19(1):33-40.
12. Grinshpoon A., Barchana M., Ponizovsky A., Lipshitz I., Nahon D., Tal O., Weizman A., Levav I. Cancer in schizophrenia: is the risk higher or lower?. Schizophr. Res. 2005, 73(2-3):333-341.
13. Israel Center for Disease Control Trends in Morbidity and Mortality of Malignant Diseases in Israel, 1970-1995. Publication No. 163 1998, Israel Center for Disease Control, Jerusalem.
14. Israel National Cancer Registry Cancer in Israel-Annual Reports of the Israel National Cancer Registry 2007, Ministry of Health, Jerusalem, Accessed March 19, 2012. http://www.health.gov.il/icr.
15. Juvonen H.J., Reumanen A., Haukka J.K., Lonnqvist J.K. The incidence of schizophrenia is low in a nationwide sample of patients with insulin-dependent diabetes mellitus. Mol. Psychiatry 1999, 4(S1):20.
16. Levav I., Lipshitz I., Novikov I., Pugachova I., Kohn R., Barchana M., Ponizovsky A., Werner H. Cancer risk among parents and siblings of patients with schizophrenia. Br. J. Psychiatry 2007, 190:156-161.
17. Lichtenberg P., Kaplan Z., Grinshpoon A., Feldman D., Nahon D. The goals and limitations of Israel's psychiatric case register. Psychiatr. Serv. 1999, 50(8):1043-1048.
18. Lichtenstein P., Holm N.V., Verkasalo P.K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 2000, 343(2):78-85.
19. Lichtermann D., Ekelund J., Pukkala E., Tanskanen A., Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch. Gen. Psychiatry 2001, 58(6):573-578.
20. Mental Health in Israel, 2008. Department of Information and Evaluation Ministry of Health (2004) Mental Health in Israel. Statistical Annual. Jerusalem. Accessed February 7, 2012. http://www.old.health.gov.il/download/forms/mentalReport2008.pdf.
21. Oken R.J., Schulzer M. At issue: schizophrenia and rheumatoid arthritis: the negative association revisited. Schizophr. Bull. 1999, 25(4):625-638.
22. Owen M.J., Williams N.M., O'Donovan M.C. The molecular genetics of schizophrenia: new findings promise new insights. Mol. Psychiatry 2004, 9:14-27.
23. Park J.K., Lee H.J., Kim J.W., Park Y.H., Lee S.S., Chang H.I., Song J.Y., Yoon D.J., Bahn G.H., Shin Y.H., Kim Y.J., Kim S.A., Choe B.K., Kim C.J., Chung J.H. Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients. Schizophr. Res. 2004, 67(1):71-74.
24. Parkin D.M., Whelan S.L., Ferlay J., Teppo L., Thomas D.B. Cancer Incidence in Five Continents 2002, vol. VIII. International Agency for Research on Cancer, Lyon, France.
25. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
26. Rabinowitz J., Slyuzberg M., Ritsner M., Mark M., Popper M., Ginath Y. Changes in diagnosis in a 9-year national longitudinal sample. Compr. Psychiatry 1994, 35(5):361-365.
27. Shi J., Gershon E.S., Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr. Res. 2008, 104(1-3):96-107.
28. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757.
29. So H.C., Gui A.H., Cherny S.S., Sham P.C. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet. Epidemiol. 2011, 35(5):310-317.
30. Stratton J., Pharoah P., Smith S., Easton D., Ponder B. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br. J. Obstet. Gynaecol. 1998, 105:493-499.
31. Torrey E.F., Yolken R.H. The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both?. Brain Behav. Immun. 2001, 15(4):401-410.
32. Weinberger D.R. Genetic mechanisms of psychosis: in vivo and postmortem genomics. Clin. Ther. 2005, 27(Suppl. A):S8-S15.
33. Weiser M., Kanyas K., Malaspina D., Harvey P.D., Glick I., Goetz D., Karni O., Yakir A., Turetsky N., Fennig S., Nahon D., Lerer B., Davidson M. Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr. Psychiatry 2005, 46(1):38-42.
34. Williams N.M., Preece A., Spurlock G., Norton N., Williams H.J., Zammit S., O'Donovan M.C., Owen M.J. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol. Psychiatry 2003, 8(5):485-487.
35. Yang J., Visscher P.M., Wray N.R. Sporadic cases are the norm for complex disease. Eur. J. Hum. Genet. 2010, 18(9):1039-1043.